Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for functional dyspepsia with duodenal eosinophilia
ACTRN12615000150549Phase 2Completed
- Sponsor
- University of Newcastle
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide in functional dyspepsia (FD), sponsored by University of Newcastle. Primary endpoints: Symptom reduction during objective nutrient challenge test and Histological eosinophil quantitation and immunopathological evaluation. Started Dec 2015; status: completed.
02
Drugs
budesonide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ACTRN12615000150549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000150549.